Holding(s) in Company

RNS Number : 1723X

Dechra Pharmaceuticals PLC

10 August 2009

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights		X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Full name of person(s) subject to the notification obligation:	Schroders plc
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached:	07.08.09
6. Date on which issuer notified:	10.08.09
7. Threshold(s) that is/are crossed or reached:	15% - 16%

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights
			Direct	Direct	Indirect	Direct	Indirect
Ordinary	13,319,102	10,454,094	13,544,102	N/A	10,679,094	N/A	16.28%
GB0009633180

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/  Conversion  Period	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Exercise  price	Expiration  date	Exercise/ Conversion  period	Number of voting  rights instrument  refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)
Number of voting rights	Percentage of voting rights
10,679,094	16.28%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

SCHRODER INVESTMENT MANAGEMENT LIMITED              10,173,594      15.51% SCHRODER INVESTMENT MANAGEMENT NORTH  AMERICA LIMITED                                                                          505,500       0.77%

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	This shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.
14. Contact name:	Taryn O'Donoghue
15. Contact telephone number:	020 7658 6000

 

END

 

 

HOLDGGMRZGVGLZM